© American Speech-Language-Hearing Association
Effects of Levodopa on Laryngeal Muscle Activity for Voice Onset and Offset in Parkinson Disease
1 Laryngeal and Speech Section Medical Neurology Branch National Institute of Neurological Disorders and Stroke Bethesda, MD
2 Mathematical Statistics Program Department of Mathematics University of Maryland College Park
3 Human Motor Control Section Medical Neurology Branch National Institute of Neurological Disorders and Stroke Bethesda, MD
ludlowc{at}ninds.nih.gov
The laryngeal pathophysiology underlying the speech disorder in idiopathic Parkinson disease (IPD) was addressed in this electromyographic study of laryngeal muscle activity. This muscle activity was examined during voice onset and offset gestures in 6 persons in the early stages of IPD who were not receiving medication. The purpose was to determine (a) if impaired voice onset and offset control for speech and vocal fold bowing were related to abnormalities in laryngeal muscle activity in the nonmedicated state and (b) if these attributes change with levodopa. Blinded listeners rated the IPD participants' voice onset and offset control before and after levodopa was administered. In the nonmedi-cated state, the IPD participants' vocal fold bowing was examined on nasoendo-scopy, and laryngeal muscle activity levels were compared with normal research volunteers. The IPD participants were then administered a therapeutic dose of levodopa, and changes in laryngeal muscle activity for voice onset and offset gestures were measured during the same session. Significant differences were found between IPD participants in the nonmedicated state:those with higher levels of muscle activation had vocal fold bowing and greater impairment in voice onset and offset control for speech. Similarly, following levodopa administration, those with thyroarytenoid muscle activity reductions had greater improvements in voice onset and offset control for speech. In this study, voice onset and offset control ifficulties and vocal fold bowing were associated with increased levels of aryngeal muscle activity in the absence of medication.
KEY WORDS: thyroarytenoid muscle, dysphonia, pathophysiology, idiopathic Parkinson disease, vocal fold movement
Submitted on October 30, 2000
Accepted on August 14, 2001
CiteULike 
Connotea 
Delicious 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  C. E. Stepp, G. R. Merchant, J. T. Heaton, and R. E. Hillman Effects of Voice Therapy on Relative Fundamental Frequency During Voicing Offset and Onset in Patients With Vocal Hyperfunction J Speech Lang Hear Res, October 1, 2011; 54(5): 1260 - 1266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Stepp, R. E. Hillman, and J. T. Heaton The Impact of Vocal Hyperfunction on Relative Fundamental Frequency During Voicing Offset and Onset J Speech Lang Hear Res, October 1, 2010; 53(5): 1220 - 1226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Feng, V. M. Henriquez, J. R. Walters, and C. L. Ludlow Effects of Dopamine D1 and D2 Receptor Antagonists on Laryngeal Neurophysiology in the Rat J Neurophysiol, August 1, 2009; 102(2): 1193 - 1205. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Blitzer, R. L. Crumley, S. H. Dailey, C. N. Ford, M. K. Floeter, A. D. Hillel, H. T. Hoffmann, C. L. Ludlow, A. Merati, M. C. Munin, et al. Recommendations of the Neurolaryngology Study Group on laryngeal electromyography Otolaryngology -- Head and Neck Surgery, June 1, 2009; 140(6): 782 - 793. [Abstract] [Full Text] [PDF]
|
|